Intravenous prostaglandin E1 improves kidney function in patients with end stage heart failure;Verbesserung der nierenfunktion durch intravenoses prostaglandin E1 bei patienten mit terminaler herzinsuffizienz

Wiener Klinische Wochenschrift

Volumn 110, Issue 13-14, 1998, Pages 473-478

  Wutte, Michael ^a   Hülsmann, Martin ^a   Berger, Rudolf ^a   Rödler, Suzanne ^a   Frey, Bernhard ^a   Stanek, Brigitte ^a   Pacher, Richard ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Congestive heart failure; Prostaglandin E1; Renal function

Indexed keywords

CAPTOPRIL; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOBUTAMINE; DOPAMINE; FUROSEMIDE; NITRATE; PROSTAGLANDIN E1; VASODILATOR AGENT;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DRUG EFFECT; FEMALE; HEART FAILURE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FUNCTION; MALE; ORAL DRUG ADMINISTRATION; TREATMENT OUTCOME; HEMODYNAMICS; KIDNEY; KIDNEY FUNCTION TEST; MICROCIRCULATION; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULARIZATION;

ALPROSTADIL; FEMALE; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; HUMANS; INFUSIONS, INTRAVENOUS; KIDNEY; KIDNEY FUNCTION TESTS; MALE; MICROCIRCULATION; MIDDLE AGED; VASODILATOR AGENTS;

EID: 0032584378     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Druml W (1998) Herz und Niere. Wien Klin Wochenschr 110: 69-71
2. Moncada S, Flaver RL, Vane JR (1980) Prostaglandins, prostacyclin and thromboxane A2. In: Gilman AG, Goodman LLS, Gilman A (eds) The pharmacological basis of therapeutics. MacMillan, New York, pp 668-681
3. McGiff, Itskovits HD (1973) Prostaglandins and the kidney. Circ Res 33/5: 479-488
4. Horton R, Zipser R, Fichman M (1981) Prostaglandins, renal function and vascular regulation. Med Clin North Am 65/4: 891-914
5. Levenson DJ, Simmons CE, Brenner BM (1982) Arachidonic acid metabolism, prostaglandins and the kidney. Am J Med 72/2: 354-374
6. Moskowitz PS, Korobkin M, Rambo ON (1975) Diuresis and improved renal hemodynamics produced by prostaglandin E1 in the dog with norepinephrine-induced acute renal failure. Invest Radiol 10/4: 284-299
7. Pacher R, Meng P, Wutte M, Daneschwar H, Berger R, Hülsmann M, et al (1994) Pharmacologic bridging therapy before heart transplantation. First results with continuous PGE1 infusion therapy alone or in combination with catecholamines. MODS: 70-76
8. Pacher R, Stanek B, Hülsmann M, Sinzinger H (1997) Effect of prostaglandin E1 infusion in severe heart failure. Prostaglandins 53: 221-235
9. Sinzinger H, Rogatti W (1991) Prostaglandin E1. Wien Klin Wochenschr 103: 558-565
10. Tobimatsu M, Konomi K, Saito, Tsumagari T (1985) Protective effect of prostaglandin E1 on ischemia induced acute renal failure in dogs. Surgery 98: 45-53
11. Paller MS (1989) Oral prostaglandin E1 analog misoprostol reduces renal ischemic injury (Abstract). Kidney Int 35: 415
12. Wilkie ME, Davies GR, Marsh FP, Rampton DS (1992) Effects of indomethacin and misoprostol on renal function in healthy volunteers. Clin Nephrology 38: 334-337
13. Abe K, Fujino Y, Sakakibara T (1993) The effect of prostaglandin E1 during cardiopulmonary bypass on renal function after cardiac surgery. Eur J Clin Pharmacol 45: 217-220
14. Pollak R, Knight R, Mozes MF, et al (1992) A trial of the cyclosporine-associated renal dysfunction. Am J Kidney Dis 20: 336-341
15. Motwani JG, Struthers AD (1994) Interactive effects of indomethacin, angiotensin II and furosemide on renal haemodynamics and natriuresis in man. Br J Clin Pharmacol 37/4: 355-361
16. Kos T, Pacher R, Hülsmann M, Frey B, Mayer G, Yilmaz N, et al (1998) Relationship between kidney function, hemodynamic variables and circulating big endothelin levels in patients with severe refractory heart failure. Wien Klin Wochenschr 110:89-95
17. Pacher R, Globits S, Bergler J, Teufelbauer H, Wutte M, et al (1993) Clinical and neurohumoral response of patients with severe congestive heart failure treated with two different captopril dosages. Eur Heart J 14: 273-278
18. Pacher R, Stanek B, Globits S, Berger R, Hülsmann M, Wutte M, et al (1996) Effects of two different enalapril dosages on clinical, hemodynamic and neurohumoral response of patients with severe congestive heart failure. Eur Heart J 17: 1223-1232
19. Heidland A, Teschner M, Gotz R (1991) Renale Funktionsänderungen bei Herzinsuffizienz und ihre Beeinflußbarkeit durch Angiotensin-Konversionshemmer. Klin Wochenschr 69 [Suppl] 24: 65-72
20. Milot A, Lambert R, Lebel M, Cusson JR, Larochelle P (1996) Prostaglandins and renal function in hypertensive patients with unilateral renal artery stenosis and patients with essential hypertension. J Hypertens 14/6: 765-771
21. Riegger AJ (1991) Bedeutung von Prostaglandinen bei der Regulation der Nierenfunktion bei Herzinsuffizienz. Herz 16/2: 116-123
22. Mc Kenna WJ, Swedberg K, Zannad F, Daring H, et al (1994) Experience of chronic intravenous epoprostenol infusion in end-stage cardiac failure: results of FIRST. Eur Heart J 15: 36 A
23. Pacher R, Stanek B (1996) Prostaglandin E1 in heart failure: the Vienna experience. Wien Klin Wochenschr 108/16: 491-495
24. Daneschvar H, Pacher R, Rödler S, Stanek B, Hülsmann M, Grimm M, et al (1996) Acceptance of a pump-driven infusion therapy with prostaglandin E1 as a bridge to heart transplantation. Wien Klin Wochenschr 108/16: 510-514
25. Hülsmann M, Stanek B, Frey B, Berger R, Rödler S, Siegel A, et al (1996) Hemodynamic and neurohumoral effects of long-term prostaglandin E1 infusions in outpatients with severe congestive heart failure. J Heart Lung Transplant 16/5: 556-562
26. Pacher R, Stanek B, Hulsmann M, Berger R, Siegel A, Daneschvar H, et al (1997) Prostaglandin E1-bridge to cardiac transplantation: techniques, dosages, results. Eur Heart J 18: 318-329